Founded in 2017 by University of Pennsylvania researchers John Welsh and Mark Kahn, OsciFlex develops therapies and devices for venous disease, with a focus on preventing immobility-related complications such as venous thromboembolism. The Philadelphia company draws on molecular pathology research to create improved approaches to venous care, including rapid-cycling compression technology and treatments for chronic venous insufficiency.